Skip Page Header

Home > Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy countries.

European Monitoring Centre for Drugs and Drug Addiction. (2020) Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy countries. Lisbon: EMCDDA.

[img]
Preview
PDF (Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy countries) - Published Version
1MB

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments. To investigate the effects of the pandemic on and the implications for drug markets and people who use drugs in the European Neighbourhood Policy (ENP) countries, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launched a trendspotter study. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug markets and people who use drugs in south ENP countries (between March and June 2020).

Item Type
Report
Publication Type
International, Report
Drug Type
Substances (not alcohol/tobacco), Cocaine, Opioid
Intervention Type
Crime prevention
Date
December 2020
Pages
17 p.
Publisher
EMCDDA
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Lisbon
EndNote
Accession Number
HRB (Electronic Only)
Related URLs

Repository Staff Only: item control page

×

We’d welcome your feedback!

Please participate in a very brief survey so we can improve your experience of using this website.

No Thanks . Don't take survey Take Survey . Survey opens in new tab